drugset / Trial / NCT04083950

Induction of Gut Permeability by an Oral Vaccine

NCT04083950

Phase 0 Active not recruiting 10 enrolled USDA, Western Human Nutrition Research Center
NaSingle-groupOpen-labelBasic science

Summary

This study evaluates the effect of an oral typhoid vaccine on disruption of the intestinal barrier and response of the immune system. Intestinal and whole-body responses will be measured in all participants before and after the vaccine.

Timeline

Start
2019-12-04
Primary completion
2022-01-31
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 325 mg Oral
Subject Ty21a Vaccine Oral

Indications